Business Standard

Friday, January 10, 2025 | 01:14 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Cadila Healthcare gets Central govt order to supply 10 mn doses of ZyCoV-D

ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus

Cadila Healthcare gets Central govt order to supply 10 mn doses of ZyCoV-D
Premium

So far, the firm has invested around Rs 400-500 crore for developing the DNA plasmid vaccine, including setting up of manufacturing plants

Vinay Umarji Ahmedabad
Cadila Healthcare (Zydus Cadila) on Monday said it has received an order to supply 10 million doses of ZyCoV-D, the world’s first Plasmid DNA vaccine, to the Centre.

In consultation with the government, Zydus has priced the vaccine at Rs 265 per dose and the needle-free applicator is being offered at Rs 93 per dose, excluding goods and services tax (GST). “We are happy to support the government’s vaccination programme with ZyCoV-D. The needle-free application of the vaccination, we hope, will motivate many more to vaccinate and safeguard themselves against Covid, especially children and young adults in the age group of

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in